{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:16:43Z","timestamp":1793067403142,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023213","name":"European Society for Immunodeficiencies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacig.2025.100603","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T20:45:42Z","timestamp":1763325942000},"page":"100603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decreased IL-17\u2013producing TH cells as a diagnostic marker for STAT signaling\u2013related primary immunodeficiencies"],"prefix":"10.1016","volume":"5","author":[{"given":"Emese","family":"Moln\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Tahami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajnalka","family":"Andrikovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Grigoriadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Buckland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100603_bib1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacig.2025.100603_bib2","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacig.2025.100603_bib3","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.4049\/jimmunol.176.9.5652","article-title":"STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice","volume":"176","author":"Cho","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91663","article-title":"IL-23R-activated STAT3\/STAT4 is essential for Th1\/Th17-mediated CNS autoimmunity","volume":"2","author":"Lee","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacig.2025.100603_bib5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2025.100603_bib6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacig.2025.100603_bib7","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2025.100603_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108988","article-title":"Hyper IgE syndromes: a clinical approach","volume":"237","author":"Gharehzadehshirazi","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jaci.2016.04.023","article-title":"Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T(H)17 cell differentiation","volume":"138","author":"Keles","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib10","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/ncomms5603","article-title":"DOCK8 regulates protective immunity by controlling the function and survival of ROR\u03b3t+ ILCs","volume":"5","author":"Singh","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacig.2025.100603_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/2010\/397291","article-title":"DOCK8 immune deficiency as a model for primary cytoskeletal dysfunction","volume":"29","author":"McGhee","year":"2010","journal-title":"Dis Markers"},{"key":"10.1016\/j.jacig.2025.100603_bib12","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1084\/jem.20110345","article-title":"DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice","volume":"208","author":"Randall","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacig.2025.100603_bib13","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1182\/blood-2012-01-407098","article-title":"DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses","volume":"119","author":"Harada","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2025.100603_bib14","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1202792","article-title":"Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity","volume":"190","author":"Ham","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","article-title":"DOCK8 deficiency: insights into pathophysiology, clinical features and management","volume":"181","author":"Biggs","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.2305","article-title":"DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation","volume":"13","author":"Jabara","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib17","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.4049\/jimmunol.1001343","article-title":"STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms","volume":"185","author":"Villarino","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib18","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacig.2025.100603_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jmedgenet-2013-101570","article-title":"New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe","volume":"50","author":"Solt\u00e9sz","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.jacig.2025.100603_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jdv.12394","article-title":"A novel large deletion of the DOCK 8 gene in a Chinese family with autosomal-recessive hyper-IgE syndrome","volume":"29","author":"Xue","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jacig.2025.100603_bib21","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s10875-021-01086-4","article-title":"Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and\/or chronic mucocutaneous candidiasis","volume":"41","author":"Frede","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections\u2014an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2025.100603_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MOP.0000000000000031","article-title":"Primary immunodeficiencies underlying fungal infections","volume":"25","author":"Lanternier","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jacig.2025.100603_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib26","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00439-020-02141-7","article-title":"Human inborn errors of immunity underlying superficial or invasive candidiasis","volume":"139","author":"Puel","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacig.2025.100603_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/ACI.0b013e3283184210","article-title":"Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3","volume":"8","author":"Paulson","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1203\/PDR.0b013e31819dc8c5","article-title":"Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes","volume":"65","author":"Freeman","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacig.2025.100603_bib29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jacig.2025.100603_bib30","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacig.2025.100603_bib31","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3390\/ijms19082265","article-title":"STAT3 in skeletal muscle function and disorders","volume":"19","author":"Guadagnin","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacig.2025.100603_bib32","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/sj.onc.1203525","article-title":"Complex roles of Stat1 in regulating gene expression","volume":"19","author":"Ramana","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jacig.2025.100603_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job\u2019s syndrome: recurrent, \u201ccold,\u201d staphylococcal abscesses","volume":"287","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2025.100603_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2011.06387.x","article-title":"Hyper-IgE syndrome update","volume":"1250","author":"Sowerwine","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacig.2025.100603_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/302547","article-title":"Genetic linkage of hyper-IgE syndrome to chromosome 4","volume":"65","author":"Grimbacher","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacig.2025.100603_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2011.03.018","article-title":"Age-associated alteration in naive and memory Th17 cell response in humans","volume":"140","author":"Lee","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacig.2025.100603_bib38","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacig.2025.100603_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620929225","article-title":"Rapid and precise diagnosis of T. marneffei pulmonary infection in a HIV-negative patient with autosomal-dominant STAT3 mutation: a case report","volume":"14","author":"Zhang","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jacig.2025.100603_bib40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jacig.2025.100603_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacig.2025.100603_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nri2433","article-title":"Cytokine-mediated regulation of antimicrobial proteins","volume":"8","author":"Kolls","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib43","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jaci.2013.02.038","article-title":"Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism","volume":"131","author":"Hsu","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108645","article-title":"A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis","volume":"223","author":"Kasap","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100603_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jacig.2025.100603_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jacig.2025.100603_bib47","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/nprot.2015.124","article-title":"Next-generation diagnostics and disease-gene discovery with the Exomiser","volume":"10","author":"Smedley","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jacig.2025.100603_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41525-024-00456-2","article-title":"Efficient reinterpretation of rare disease cases using Exomiser","volume":"9","author":"Vestito","year":"2024","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jacig.2025.100603_bib49","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325002048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:56:55Z","timestamp":1771876615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2772829325002048"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100603","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased IL-17\u2013producing TH cells as a diagnostic marker for STAT signaling\u2013related primary immunodeficiencies","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100603"}}